Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
05/23/2002 | WO2001074344A3 Small organic molecule regulators of cell proliferation |
05/23/2002 | WO2001072294A3 Method of treating hepatitis delta viral infection |
05/23/2002 | WO2001049651A3 Aminomethyl-phenyl-cyclohexanone derivatives |
05/23/2002 | WO2001047946A9 GFRα1-RET SPECIFIC AGONISTS AND METHODS THEREFOR |
05/23/2002 | WO2001041760A9 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
05/23/2002 | WO2000071121A9 Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations |
05/23/2002 | WO2000063204A3 Substituted azoles |
05/23/2002 | WO2000054765A8 Method of treating eating disorders |
05/23/2002 | US20020062008 Novel human beta2 integrin alpha subunit |
05/23/2002 | US20020061923 Diacid isoindoleine amide derivative |
05/23/2002 | US20020061919 Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-{(2-methyl-1h-imidazol-1-yl)methyl}-4h-carbazol-4-one |
05/23/2002 | US20020061914 Benzothiazole, benzooxazole and benzoimidazole derivatives as sodium or calcium channel modulators |
05/23/2002 | US20020061911 Enantiomers of 6-amino EM-12 and method of use |
05/23/2002 | US20020061910 Optically pure reboxetine or its methanesulfonate salt inhibits reuptake of norepinephrine |
05/23/2002 | US20020061887 For therapy and prophylaxis of cardiovascular diseases such as hypertension, angina pectoris, cardiac insufficiency, thromboses or atherosclerosis |
05/23/2002 | US20020061877 Substituted cyclic amine metalloprotease inhibitors |
05/23/2002 | US20020061853 Caspase inhibtors and uses thereof |
05/23/2002 | US20020061304 Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor |
05/23/2002 | CA2448729A1 Piperazinyl and piperidyl substituted heterocyclic compounds |
05/23/2002 | CA2429628A1 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors |
05/23/2002 | CA2429329A1 Bombesin receptor antagonists |
05/23/2002 | CA2429195A1 Immunoglobulin superfamily proteins |
05/23/2002 | CA2429047A1 Treatment of anti-depression drug-induced sexual dysfunction with apomorphine |
05/23/2002 | CA2428837A1 Microspheres of pancreatic enzymes with high stability |
05/23/2002 | CA2428754A1 Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
05/23/2002 | CA2428527A1 (dihydro)isoquinoline derivatives as phosphodiesterase inhibitors |
05/23/2002 | CA2428519A1 Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists |
05/23/2002 | CA2427656A1 Crf receptor antagonists and methods relating thereto |
05/23/2002 | CA2427296A1 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders |
05/23/2002 | CA2426089A1 Bombesin receptor antagonists |
05/22/2002 | EP1207160A1 Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one |
05/22/2002 | EP1206938A1 Gastrokinetic bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)- piperdine derivatives |
05/22/2002 | EP1206935A1 Th2 differentiation inhibitors |
05/22/2002 | EP1206934A1 Blockade of sodium channels by phenol derivatives |
05/22/2002 | EP1206930A2 An oral treatment/care agent |
05/22/2002 | EP1206573A1 26 human secreted proteins |
05/22/2002 | EP1206563A1 Genetically altered dendritic cells transduced with adeno-associated virus (aav), methods of producing said cells and uses thereof |
05/22/2002 | EP1206553A2 Isomerase proteins |
05/22/2002 | EP1206543A2 Membrane associated proteins |
05/22/2002 | EP1206541A1 Dendritic enriched secreted lymphocyte activation molecule |
05/22/2002 | EP1206527A1 Treatment of inflammatory or malignant disease using dnazymes |
05/22/2002 | EP1206491A1 Tgf-beta receptor polynucleotides, polypeptides, and antibodies |
05/22/2002 | EP1206485A2 New effectors of dipeptidyl peptidase iv for topical use |
05/22/2002 | EP1206472A1 Oxazole and thiazole derivatives as neurotrophin production/secretion promoting agent |
05/22/2002 | EP1206471A1 Interleukin-5 inhibiting 6-azauracil derivatives |
05/22/2002 | EP1206467A1 N-heterocyclic derivatives as nos inhibitors |
05/22/2002 | EP1206466A1 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
05/22/2002 | EP1206444A1 Compounds that inhibit tryptase activity |
05/22/2002 | EP1206283A2 Improved cellular uptake of bioactive agents |
05/22/2002 | EP1206265A1 Src kinase inhibitor compounds |
05/22/2002 | EP1206263A1 Ft-raman spectroscopic measurement of omeprazole isomer ratio in a composition |
05/22/2002 | EP1206262A1 Npy antagonists: spiroisoquinolinone derivatives |
05/22/2002 | EP1206260A1 Src kinase inhibitor compounds |
05/22/2002 | EP1152776B1 Biodegradable, injectable oligomer-polymer composition |
05/22/2002 | EP0894093B1 Soluble tachykinin antagonists, the preparation and use thereof |
05/22/2002 | EP0792110B1 Silicone compositions |
05/22/2002 | EP0685463B1 Indolin-2-one derivative |
05/22/2002 | EP0665754B1 Antimicrobial peptides |
05/22/2002 | EP0583360B1 Compositions for the prevention and/or treatment of pathological processes |
05/22/2002 | CN1350536A 氨基甲酰基四氢吡啶衍生物 Carbamoyl tetrahydropyridine derivative |
05/22/2002 | CN1350530A 酰胺衍生物 Amide derivatives |
05/22/2002 | CN1350462A Lactobacillus strains capable of preventing diarrhoea caused by pathogenic bacteria and rotaviruses |
05/22/2002 | CN1350461A Lactobacillus strain preventing diarrhoea pathogenic bacteria |
05/22/2002 | CN1350460A Lactic acid bacteria strains capable of preventing diarrhoea |
05/22/2002 | CN1350458A Protease inhibitors |
05/22/2002 | CN1350435A A composition containing carvacrol and thymol for use as abactericide |
05/22/2002 | CN1350002A Deformed streptococcus adherence resisting polypeptide mixture |
05/22/2002 | CN1349828A Beautifying health oral liquid containing cell regulating factor and its making process |
05/22/2002 | CN1349826A Lingguo extract capsule and its prepn. method |
05/22/2002 | CN1349825A Compound Chinese medicine prepn. containing Jisongrong and Its prepn process |
05/22/2002 | CN1349824A Production process of healthy soybean oral liquid |
05/22/2002 | CN1349823A Making process of enzyme degrading oral liquid |
05/22/2002 | CN1349807A Colitis treating Chinese medicine prepn |
05/22/2002 | CN1349799A Chinese medicine Hanhui prepn |
05/22/2002 | CN1349798A Blood pressure lowering and heart protecting tablet and its production process |
05/22/2002 | CN1085209C 5,11-dihydrodibenz [b,3][1,4] oxazepine derivatives and drug compoistions contaiing the derivatives |
05/22/2002 | CN1085084C Medicine for treating acute-chronic abdominal troubles and its preparing method |
05/22/2002 | CN1085079C Use of granisetron for the treatment of post-operative hausea and uomitting |
05/21/2002 | US6392045 9-azobicyclo[3.3.1] non-2-ene derivatives as cholinergic ligands at nicotinic ACH receptors |
05/21/2002 | US6392040 Cyclopentene compounds useful as antagonists of the motilin receptor |
05/21/2002 | US6392039 Coupling; salt formation |
05/21/2002 | US6392028 Functional DNA clone for hepatitis C virus (HCV) and uses thereof |
05/21/2002 | US6391917 Analgesic |
05/21/2002 | US6391909 Anandamide inhibitors as analgesic agents |
05/21/2002 | US6391908 Oxime amide indole type sPLA2 inhibitors |
05/21/2002 | US6391893 Anticancer agents |
05/21/2002 | US6391891 Bicyclic compounds as ligands for 5-HT1 receptors |
05/21/2002 | US6391887 3,4-Dihydroquinoline derivatives as nitrogen monoxide synthase (NOS) inhibitors |
05/21/2002 | US6391878 Compounds such as (4,7-dimethylbenzimidazol-5-yl)guanidine; treating nasal congestion, otitis media, asthma, pain, migraine, gastrointestinal disorder, ulcer |
05/21/2002 | US6391616 Oidiodendron strain for the production of terpenoid lactone compounds |
05/21/2002 | US6391588 Nucleotides squences coding preferential amino acid sequences for use in treating bone disorder in mammals |
05/21/2002 | CA2268327C 3-carboxamide derivatives of 5h-pyrrolo[2,1-c][1,4]-benzodiazepines |
05/21/2002 | CA2153254C Cloning of enterokinase and method of use |
05/17/2002 | CA2363147A1 Stable lactase compositions |
05/16/2002 | WO2002038778A1 Differentiation-inducing substances |
05/16/2002 | WO2002038744A2 Proteases |
05/16/2002 | WO2002038730A2 Novel human potassium channel beta subunit |
05/16/2002 | WO2002038607A2 A 'bach' g protein coupled receptor polypeptide and polynucleotide encoding this receptor |
05/16/2002 | WO2002038594A1 Novel therapeutic compositions for treating infection by lawsonia spp |
05/16/2002 | WO2002038575A1 Glycerophosphoinositol derivatives as modulators of cytosolic a2 phospholipase |